<ul><li>Size of the site: 8,837 m² </li><li>Production &amp; packaging: 3,745 m² </li><li>Laboratories: 345 m²</li><li>FTE: 150</li></ul>

<ul><li>Production of Semisolids<ul><li>Creams</li><li>Ointments</li><li>Gels</li><li>Suppositories</li></ul></li><li>Production of non-sterile liquids</li><li>Bulk production, filling, full control and release on the market</li><li>OEB 1-5</li><li>Quality services</li></ul>

<ul><li>Support to tech transfer activities (scale up / process validation / analytical validation)</li></ul>

<ul><li>Jars</li><li>Bottles</li><li>Tubes</li><li> Suppositories</li><li>Integrated serialization &amp; aggregation </li></ul>

<ul><li>Manufacturing licenses<ul><li>EU GMP</li></ul></li><li>Non EU-GMP certificates<ul><li>Belarussian MoH</li><li>SFDA</li><li>Russia</li><li>ANVISA</li></ul></li><li>ISO certificates<ul><li>ISO 9001</li><li>ISO 14001</li><li>ISO 45001</li><li>ISO 13485</li></ul></li></ul>

<ul><li>Rx</li><li>OTC</li><li>Medical devices</li><li>Cosmetics</li><li>Veterinary products</li></ul>

Technologies

<ul><li>Bulk manufacturing <ul><li>4 turboemulsifier (1,000 – 5,000 l)</li><li>1 mixer for liquids and gel (1,000 l)</li><li>2 mixer for suppositories (500 l)</li></ul></li><li>Filling <ul><li>6 filling line for creams </li><li>2 filling lines for jar </li><li>2 filling line for suppositories </li><li>1 filling line for liquids</li></ul></li></ul>
<ul><li>Laboratory<ul><li>11 HPLC</li><li>1UPLC</li><li>2 GC</li><li>1 UV</li><li>1 IR</li><li>1 polarimeter</li><li>1 NIR</li><li>2 titrator</li></ul></li></ul>

Products

<ul><li>Antibiotics for dermatological use </li><li>Anti-diarrheals, intestinal anti-inflammatory / anti-infective agents </li><li>Anti-fungals for dermatological use </li><li>Anti-histamines for systemic use </li><li>Anti-hemmorrhoidal</li><li>Anti-inflammatory and anti-rheumatic products </li><li>Corticosteroids, dermatological preparations </li><li>Emollients and protectives </li><li>Gynecological anti-infectives and anti-septics </li><li>Nasal sprays </li><li>Otologicals </li><li>Vasoprotectives</li></ul>

Codice Etico

<a href="https://www.aenova-group.com/content/Codice_Etico_Temmler_Italia.pdf" target="_blank" rel="noreferrer noopener">Codice Etico Aenova Carugate (Temmler Italia Srl)</a>

Carugate

The Aenova site in Carugate has been producing and packaging semisolids for pharmaceuticals, medical devices and cosmetics as well as non-sterile liquids since 1994.

The Aenova site in Carugate has been producing and packaging semisolids for pharmaceuticals and cosmetics as well as non-sterile liquids...

Carugate - Aenova Group

employees

certifications & approvals

square meter

Homogenizer Carugate Aenova

Line Carugate Aenova

Lab Carugate Aenova

Filling creme Carugate Aenova

Tank filling Carugate Aenova

Exterior view Carugate Aenova

Facts

Location Carugate, Italy
Competence Center Semisolids and non-sterile liquids

The Aenova site in Carugate has been producing and packaging semisolids for pharmaceuticals, medical devices and cosmetics as well as non-sterile liquids since 1994.
These include creams and gels, rectal and ovarian suppositories. Carugate can produce both human and veterinary products.

Aenova invests in additional production capacity for semi-solids and non-sterile liquids at their Carugate site

12/10/2023 - Aenova invests in additional production capacity for semi-solids and non-sterile liquids

Carugate, 12/10/2023

Aenova is enhancing the existing infrastructure in four areas at its Carugate site (Italy), covering both pharmaceutical and cosmetic products. With an investment of around 10 million Euros, Aenova will be able to significantly increase its production capacity to meet increased market demand.
Semi-solids for pharmaceuticals, medical devices and cosmetics, as well as non-sterile liquids, continue to experience increasing demand. To meet these growing market needs, Aenova, a world leading Contract Development & Manufacturing Organisation (CDMO), is installing more modern and efficient equipment at its Carugate site (Italy). The investment of around 10 million Euros will enable four major projects to be implemented: A new filling line for non-sterile liquids, a more efficient turbo-emulsifier, a more complex filling line for cosmetics and a larger warehouse. 
 Aenova's Carugate site, with 145 employees, has been producing and packaging semi-solids for pharmaceuticals, medical devices and cosmetics, as well as non-sterile liquids, since 1994. The new filling line for non-sterile liquids will increase capacity to more than 10 million units per year. The versatile line also enables the filling of bottles with variable dosages from 10 ml to 350 ml and different types of closures (screw or crimp of metal and plastic cap, spray, dropper). The new turbo-emulsifier means that the facility can now manufacture batch sizes ranging from 300 litres to 5,000 litres. In addition to the increase in production, it will also be possible to produce other types of products, such as flammable liquids, as the area is ATEX rated. In the cosmetics sector, the current filling line will be replaced by a new modern high-speed line that can fill a wider variety of tubes of special sizes and shapes, including those with cannulas. The newly built warehouse next to the plant increases capacity by almost 3,000 pallet spaces, providing more than sufficient in-house GMP storage to meet the growing demand. "With the implementation of these four projects, we will effectively have a completely new plant with more modern and more efficient equipment by the end of 2023. This will not only enhance our capabilities, but also our position within the marketplace as a "Centre of Excellence for semi-solid and non-sterile liquid manufacturing", explains Marco Falzolgher, Managing Director of the Aenova site in Carugate. "Not only will we be able to better respond to market needs and customer requests, but we will also be able to expand our service offering to reliably provide products to patients and consumers around the world." "Within the overall investments of the Aenova Group, the capacity expansions for semi-solids and non-sterile liquids in Carugate are an important strategic building block. In line with our motto "Excellence beyond manufacturing", we want to be a reliable and agile partner for our customers in key market segments," comments Roel de Nobel, Chief Operations Officer of Aenova Group. The capacity expansions are expected to be completed by the end of 2023. Additional customer orders can be produced from 2024.

Auf einen Blick

At a glance

Jan Kengelbach

Dr. Peter Waller

Dr Peter Waller

Tim Bauer

Anne-Sophie Bonte, Ph.D.

Florent Bordet, Ph.D.

Florent Bordet, Ph. D.

Neil Jones

Management

Aufsichtsrat

Supervisory Board

Bad Aibling

Cornu

Feldkirchen

Greensboro

Gronau

Killorglin

Kirchberg

Latina

Marburg

Münster

Regensburg

Sisseln

Starnberg

Tittmoning

Standorte

Manufacturing Sites

Compliance

Nachhaltigkeit

Corporate Sustainability

Werte

Values

Ressourcen

Resources

Unternehmen

Company

Tablets

Hard Capsules

Effervescents, Lozenges, Chewables

High potent solids

Controlled release

Beta Lactam Antibiotics

Solida

Solids

Liquid Vials

Prefilled Syringes

Beta Lactams

Fill & Finish of Biologics

Sterile Technologien

Sterile Technologies

Non-Sterile Liquids

Ointments and creams

Suppositories

Semisolida & nicht sterile Flüssigkeiten

Semi-solids & Non sterile Liquids

Soft Gelatin Capsules

VegaGels®

Weichgelatine Kapseln

Softgel Capsules

Blister

Vials & Ampoules

Bottles & Tubes, Cans & Jars

Cartons & Boxes

Services

Verpackungs-Services

Packaging Services

Qualität

Quality

Pharmazeutische Fertigung

Pharmaceutical Manufacturing

Semisolids & Liquids

Soft Gel Capsules

Sterile Injectables

Entwicklung von Arzneimitteln

Drug Product Development

Analytische Entwicklung

Analytical Development

Clinical Trial Supply Management

Regulatorische Unterstützung

Regulatory Support

Technologie Transfer

Technology Transfer

Entwicklung & Technologie

Development & Technology Services

Haustiere

Companion Animals

Nutztiere

Farm Animals

Tiergesundheit

Animal Health

Investoren

Investor Relations

Arbeiten bei Aenova

Working at Aenova

Karrierestufen

Career Levels

Ihre Bewerbung bei Aenova

Your application at Aenova

Job Portal

Karriere

Career

News

Events

News & Events

Presse Portal

Press Portal

Carugate

The Production Plant

Manufacturing Services

Development Services

Packaging Services

Certifications & Approvals

Product Types

Address

News